Emphysema is a chronic lung condition that affects millions of people worldwide and can make everyday activities such as ...

If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

Heart failure resulting from treatments for non-cardiac medical conditions presents a significant challenge in clinical ...

PhytoRelief-Plus provides a way to address symptoms such as chronic cough and pollution-induced congestion without relying on ...

The effects of edible cannabis can take anywhere from 30 minutes to 2 hours to kick in and last anywhere from 4 to 12 hours ...

Additional 15 drugs are taken by over 5 million Americans and treat cancer, type 2 diabetes, asthma, and more WASHINGTON, D.C ...

The risk of heart attack and stroke declines, but gastrointestinal problems and joint inflammation increase: New research has shed more light on the pros and cons of weight-loss jabs.

We recently published a list of 10 Best Falling Stocks to Invest in Right Now. In this article, we are going to take a look ...

Researchers have identified new lung function and blood test cutoffs to improve timely chronic hypercapnia management in ...

Whether you are lightly exercising or are going about regular activities, COPD means you may find yourself short of breath. When that happens, stop and use these techniques to reset and get your ...

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

The expanded indication allows esketamine nasal spray to be used as a standalone treatment in adults with MDD who have not ...